Jury Rejects Feds' Claims Gilead Infringed HIV Drug Patents
By Jeff Montgomery ( May 9, 2023, 12:49 PM EDT) -- A six-member federal jury in Delaware rejected a potential billion-dollar government claim Tuesday that Gilead Sciences Inc. infringed government-owned patents when it fielded its Truvada and Descovy drugs to treat or reduce the risk of HIV infections....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.